Pharmacovigilance in practice: erythropoiesis-stimulating agents
Michael Hedenus1, Heinz Ludwig, David H Henry
1Sundsvall Hospital, Sundsvall, Sweden.
Cancer Medicine
|June 4, 2014
Summary
Pharmacovigilance (PV) ensures medical product safety through data collection and risk assessment. For erythropoiesis-stimulating agents (ESAs), PV identified and managed risks like thromboembolic events, confirming their safety when used as indicated.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Medical Product Regulation
Background:
- Pharmacovigilance (PV) is critical for monitoring medical product safety post-marketing.
- Regulatory agencies and license holders collaborate to gather diverse safety data.
- Erythropoiesis-stimulating agents (ESAs) are used for anemia but carry risks.
Purpose of the Study:
- To advance the safe use of marketed medical products.
- To illustrate PV application using Erythropoiesis-stimulating agents (ESAs) as a case study.
- To assess and mitigate risks associated with medical products.
Main Methods:
- Data collection from healthcare providers, patients, and public reports.
- Analysis of systematic reviews, meta-analyses, and clinical studies.
- Validation and assessment of safety signals to develop risk mitigation plans.
Main Results:
- PV activities led to updated ESA labeling addressing risks.
- Meta-analyses and studies confirmed increased thromboembolic event risk with ESAs.
- When used as indicated, ESAs showed no significant effect on survival or disease progression.
Conclusions:
- Pharmacovigilance effectively identifies and manages medical product risks.
- ESA labeling accurately reflects known risks, particularly thromboembolic events.
- Ongoing research will further refine understanding of ESA risks and benefits.
Keywords:
Adverse eventchemotherapy induced anemiaerythropoiesis-stimulating agentpharmacovigilancesafety signalMore Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.1K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
18.8K
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:24Factors Affecting Erythropoiesis
8.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
8.2K
01:16Therapeutic Drug Monitoring: Overview and Classification
638
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
638
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97